1048OM7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients (pts) with advanced SCCHN: Results from a phase I cohort. (23rd October 2018) - Cho, B C; Daste, A; Ravaud, A; Salas, S; Isambert, N; McClay, E; Awada, A; Borel, C; Gulley, J; Ojalvo, L; Helwig, C; Rolfe, P A; et al.